Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-756423 and Indinavir for HIV Infection
NCT00002424Phase 2Suspended
- Sponsor
- Merck & Co.
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of L-756423 in human immunodeficiency virus infection (HIV) (4 arms), sponsored by Merck & Co. Status: suspended.
02
Drugs
L-756423
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002424.